➀

16-1540_PPD-25-245 Extraneal PL-path.indd 1 25/7/16 16:46

Clinical Trial Adverse Reactions †

System Organ Class (SOC)

Preferred MedDRA Term Frequency*

Frequency Percentage

or Ratio N=493

➁

16-1540_PPD-25-245 Extraneal PL-path.indd 2 25/7/16 16:46

Clinical Trial Adverse Reactions †

System Organ Class (SOC)

Preferred MedDRA Term Frequency*

Frequency Percentage

or Ratio N=493

➂

16-1540_PPD-25-245 Extraneal PL-path.indd 3 25/7/16 16:46